Lavender Oil-Potent Anxiolytic Properties via Modulating Voltage Dependent Calcium Channels
Open Access
- 29 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4), e59998
- https://doi.org/10.1371/journal.pone.0059998
Abstract
Recent clinical data support the clinical use of oral lavender oil in patients suffering from subsyndromal anxiety. We identified the molecular mechanism of action that will alter the perception of lavender oil as a nonspecific ingredient of aromatherapy to a potent anxiolytic inhibiting voltage dependent calcium channels (VOCCs) as highly selective drug target. In contrast to previous publications where exorbitant high concentrations were used, the effects of lavender oil in behavioral, biochemical, and electrophysiological experiments were investigated in physiological concentrations in the nanomolar range, which correlate to a single dosage of 80 mg/d in humans that was used in clinical trials. We show for the first time that lavender oil bears some similarities with the established anxiolytic pregabalin. Lavender oil inhibits VOCCs in synaptosomes, primary hippocampal neurons and stably overexpressing cell lines in the same range such as pregabalin. Interestingly, Silexan does not primarily bind to P/Q type calcium channels such as pregabalin and does not interact with the binding site of pregabalin, the α2δ subunit of VOCCs. Lavender oil reduces non-selectively the calcium influx through several different types of VOCCs such as the N-type, P/Q-type and T-type VOCCs. In the hippocampus, one brain region important for anxiety disorders, we show that inhibition by lavender oil is mainly mediated via N-type and P/Q-type VOCCs. Taken together, we provide a pharmacological and molecular rationale for the clinical use of the oral application of lavender oil in patients suffering from anxiety.This publication has 40 references indexed in Scilit:
- Stress, glucocorticoids and glutamate release: Effects of antidepressant drugsNeurochemistry International, 2011
- Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder – evidence from clinical trialsWiener Medizinische Wochenschrift, 2010
- Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of anxiety disorders and related conditionsPlanta Medica, 2010
- TRPC3 Channels Are Necessary for Brain-Derived Neurotrophic Factor to Activate a Nonselective Cationic Current and to Induce Dendritic Spine FormationJournal of Neuroscience, 2007
- Ca2+ channel α2δ ligands: novel modulators of neurotransmissionTrends in Pharmacological Sciences, 2007
- Identification of the α 2 -δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalinProceedings of the National Academy of Sciences of the United States of America, 2006
- Linalool modifies the nicotinic receptor–ion channel kinetics at the mouse neuromuscular junctionPharmacological Research, 2000
- A family of γ‐like calcium channel subunitsFEBS Letters, 2000
- Psychological Weil-Being: Meaning, Measurement, and Implications for Psychotherapy ResearchPsychotherapy and Psychosomatics, 1996
- Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studiesEuropean Journal of Pharmacology: Molecular Pharmacology, 1993